Boards are heads-down on executive compensation fundamentals while tasked with numerous emerging issues. Here’s how to balance the demands.
Insights and Research
The Pearl Meyer team includes industry experts with deep knowledge and experience in all aspects of compensation and leadership. Here they provide valuable insight on emerging issues and developing trends. They offer compelling solutions for challenging situations and advice on maximizing opportunities. Read on and learn more about how Pearl Meyer’s team can help you connect pay, people, and performance.
Showing 28-36 of 318 Results
Getting the Most From Your Bank Advisory Board
Advisor Blog
|
Forty percent of regional banks have advisory boards in place, but they are not always fully or efficiently leveraged. Here’s how to improve the ROI.
The Compensation Committee Blueprint
Research Report
|
A visionary, yet practical roadmap for the next-generation compensation and human capital committee
A Quick Glance at the Radar for Compensation Committees
Advisor Blog
|
Several new regulatory executive compensation developments are taking shape. Here’s what you need to know for Spring and Summer committee meetings.
Pay Versus Performance Watch: The First Filers
Advisor Blog
|
PVP disclosure data and trends based on this year’s first 60 public filings.
The Softening Economy and Incentive Design: A Compensation Committee Top Concern
Advisor Blog
|
There are still difficulties with goal-setting and investors may become impatient. Here are ideas for creating effective incentives amid uncertainty.
Are Today’s Directors Underpaid?
Advisor Blog
|
Data show board compensation grows at a very slow pace; is it enough to attract the caliber of director talent required for board service today?
Decoding the SEC’s Updates on Pay Versus Performance Rules
Client Alert
|
We outline the new information to take into account as companies draft PVP disclosures, and note which issues remain open for imminent filers.
Recent and Planned Compensation Practices for Life Sciences Companies
Article
|
Despite a slowing economy and increased prevalence of job cuts, the market for talent in life sciences remains strong, as does wage inflation.
Juggling Biotech Equity Grant Size, Dilution, and Retention
Advisor Blog
|
A decline in share prices creates challenges in the current equity grant cycle. Our data show how biotech companies are making adjustments.